#closed-end-fund

[ follow ]
#investment #gabelli-dividend--income-trust #covered-calls #dividend #healthcare #income-generation
from24/7 Wall St.
1 week ago

GRX's 14-Year Dividend Streak Holds Firm as Rate Cuts Ease Leverage Costs

Gabelli Healthcare & WellnessRx Trust has maintained quarterly payments for over 14 consecutive years with no missed or skipped dividends, recently raising its distribution to $0.17 per share.
Business
#gabelli-dividend--income-trust
from24/7 Wall St.
1 week ago
Business

Mastercard and JPMorgan dividends fuel this fund's outsized 6.2% payout

Gabelli Dividend & Income Trust offers a 6.2% annual yield, but income safety relies on understanding its structure and earnings.
from24/7 Wall St.
1 week ago
Business

6.3% Monthly Yield, up 7% in 6 Months. Is There a Catch With This CEF?

Gabelli Dividend & Income Trust offers a consistent monthly distribution with a strong historical performance and a focus on dividend-paying stocks.
Business
from24/7 Wall St.
1 week ago

Mastercard and JPMorgan dividends fuel this fund's outsized 6.2% payout

Gabelli Dividend & Income Trust offers a 6.2% annual yield, but income safety relies on understanding its structure and earnings.
Business
from24/7 Wall St.
1 week ago

6.3% Monthly Yield, up 7% in 6 Months. Is There a Catch With This CEF?

Gabelli Dividend & Income Trust offers a consistent monthly distribution with a strong historical performance and a focus on dividend-paying stocks.
more#gabelli-dividend--income-trust
Venture
from24/7 Wall St.
1 week ago

Why retirees are buying this closed-end fund yielding 8% on venture-stage tech

BlackRock Science & Technology Term Trust offers an 8.3% yield through a venture-stage technology portfolio and covered call writing strategy.
Business
fromFortune
5 months ago

Hedge fund billionaire Bill Ackman is reportedly readying Pershing Square and a new fund to go public as soon as early next year | Fortune

Bill Ackman plans a double public offering for Pershing Square and a new closed-end Pershing Square USA fund, potentially as early as 2026.
from24/7 Wall St.
7 months ago

Blackrock's Science and Technology Term Trust (BSTZ) Pays 11.9% Dividends

Blade Runner (1982) was a sci-fi noir film starring Harrison Ford and Rutger Hauer that has since become hailed as a classic. It featured Hauer as Roy Batty, a Replicant, with the appearance of a normal man to a casual observer, but is actually a genetically created Super-Soldier designed for combat missions, who has an "expiration date", i.e., when he is predestined to die.
Film
[ Load more ]